
About Amino Labs
Amino Labs is a company based in Toronto (Canada) founded in 2015. It operates as a Direct-to-Consumer (D2C) and EduTech. Amino Labs has raised $250 thousand across 1 funding round from investors including IndieBio. Amino Labs offers products and services including Engineer-it Kit, Zero to Genetic Engineering Hero Book, and Canvas Kit. Amino Labs operates in a competitive market with competitors including Evelo Biosciences, PathogenDX, Manus Bio, Kallyope and Limula, among others.
- Total Equity Funding$250K (USD)
in 1 rounds
- Latest Funding Round$250K (USD), Seed
Oct 2015
- Investors
Products & Services of Amino Labs
Amino Labs offers a comprehensive portfolio of products and services, including Engineer-it Kit, Zero to Genetic Engineering Hero Book, and Canvas Kit.
Kit for learning genetic engineering with bacteria.
Guidebook for beginners in genetic engineering basics.
Kit for creating art using bacteria or yeast.
Apps and channels of Amino Labs
its YouTube channel Amino Labs has 968 subscribers and 30 videos.
Videos from Amino Labs
The most watched videos on Amino Labs's YouTube channel, Amino Labs (968 subscribers). Click a video to play it here.
More on Amino Labs.
Funding Insights of Amino Labs
Amino Labs has successfully raised a total of $250K through 1 strategic funding round. The most recent funding activity was a Seed round of $250 thousand completed in October 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $250,000
- Total Rounds 1
- Last Round Seed β $250,000
- First Round $250,000
(Oct 2015)
- Investors Count 1
All 1 funding rounds of Amino Labs with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2015 | $250,000 | Seed | β | IndieBio | β |
1 investors in total: 1 institutional.
Investors in Amino Labs
Amino Labs has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include IndieBio.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Biotech startups are accelerated through IndieBio's focused programs. | – | indiebio.co | San Francisco, United States |
Investor details for Amino Labs
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Amino Labs
2 people are tracked at Amino Labs (1 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Julie Legault | CEO | Leadership |
Justin Pahara | Advisor | Team |
Complete people profiles for Amino Labs
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Amino Labs
2 dated milestones of Amino Labs, from founding to its latest funding, stage changes and deals.
- Founded Amino Labs is founded.
- Funding First funding round of $250K.
Competitors of Amino Labs
Amino Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Evelo Biosciences, PathogenDX, Manus Bio, Kallyope and Limula, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| evelobio.com | 2015 | Cambridge, United States | $166.5M | 117 | Therapeutics for inflammatory diseases, COVID-19, and cancer are developed. | |
| pathogendx.com | 2014 | Tucson, United States | $11.58M | 31 | Provider of DNA-based pathogen testing kits | |
| manusbio.com | 2011 | Cambridge, United States | $115.93M | – | Phytochemicals are developed using microbial fermentation processes. | |
| kallyope.com | 2014 | New York, United States | $479M | 84 | The gut-brain axis is explored for therapeutic and nutritional innovations. | |
| limula.ch | 2020 | – | – | – | Modular solutions for on-demand cell therapy manufacturing are provided. | |
| pbsbiotech.com | 2006 | Camarillo, United States | $70.21M | – | Developer of single-use bioreactors for the production of vaccines, therapeutic proteins, and cell therapies | |
| oxthera.com | 2005 | Stockholm, Sweden | $93.1M | – | Microbial-based drug products for hyperoxaluria treatment are developed. | |
| m2p-labs.com | 2005 | Baesweiler, Germany | – | 107 | Micro-bioreactors are provided for screening and bioprocess development. | |
| biocortex.com | 2021 | London, United Kingdom | $5M | – | Human-microbiome platform is developed for drug discovery applications. | |
| biotia.io | 2016 | Brooklyn, United States | $10.4M | – | Sequencing-based solutions are provided for hospitals to combat infections. |
Detailed competitors of Amino Labs
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Amino Labs
The website of Amino Labs (amino.bio) receives about 22.3K visits a month.
- Monthly visits22.3K
▼ 26.4% vs previous month
Websites whose visitors overlap most with Amino Labs. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
the-odin.com | the-odin.com | 100% | – | #957,630 | β |
apexbt.com | apexbt.com | 92% | – | #441,822 | β |
theminione.com | theminione.com | 90% | – | #2,316,589 | β |
| macvector.com | 86% | – | #5,246,504 | View details | |
gelanalyzer.com | gelanalyzer.com | 84% | – | #6,683,920 | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 13 similar websites and full traffic analytics for Amino Labs
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 13 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to Amino Labs
10 companies that operate in the same segment as Amino Labs (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Amino Labs
Amino Labs was founded in 2015.
Amino Labs is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
Amino Labs is a funded company, having raised a total of $250K across 1 funding round to date. The company's 1st funding round was a Seed of $250K, raised on Oct 2015.
Amino Labs is focused on developing and distributing beginner-friendly biotechnology kits and resources. These kits are designed for educational purposes, targeting students, educators, and enthusiasts in schools, homes, and makerspaces. Solutions include genetic engineering kits, bacterial art kits, and bioplastics experiments, covering sectors like education and STEM. Free resources such as virtual simulators and lesson guides are also provided to support learning and teaching in biotechnology.
Amino Labs's top competitors include PathogenDX, Manus Bio and Kallyope.
Amino Labs offers Engineer-it Kit, Zero to Genetic Engineering Hero Book, and Canvas Kit.
Amino Labs has 1 investor. Key investors include IndieBio.